The FDA said it will now review only a small number of emergency use authorization (EUA) requests for COVID-19 diagnostic…
August 5, 12:32 AM
Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG (NASDAQ: CRSP), valued at over $5.58 million, via its flagship fund.
August 2, 6:12 PM
Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(0.90) per share which beat the analyst consensus estimate of $(1.07) by 15.89 percent. This is a 12.62 percent increase over losses of $(1.03) per share from